What is the workup for hematospermia (blood in semen)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for Hematospermia (Blood in Semen)

For men with hematospermia, the diagnostic workup should be stratified by age, with men ≥40 years requiring more thorough evaluation including PSA testing, detailed history, physical examination with digital rectal examination, urinalysis, and transrectal ultrasound (TRUS) as the first-line imaging modality. 1

Initial Assessment for All Patients

  • Detailed history focusing on:

    • Duration (transient/episodic vs. persistent)
    • Associated symptoms (pain, fever, weight loss, urinary symptoms)
    • Risk factors (recent instrumentation, prostate biopsy, trauma)
    • Sexual history and potential STIs
    • Medication use (anticoagulants)
  • Physical examination:

    • Blood pressure measurement (hypertension can be associated)
    • Abdominal examination
    • Genital examination (testicular masses, urethral discharge)
    • Digital rectal examination (prostate abnormalities)
  • Basic laboratory testing:

    • Urinalysis
    • Urine culture if infection suspected
    • STI testing if indicated

Age-Based Approach

Men <40 years with single/transient episode and no risk factors:

  • Reassurance (likely benign and self-limiting)
  • No imaging typically required 2
  • Consider treating any identified infections

Men ≥40 years OR any man with persistent/recurrent hematospermia OR concerning symptoms:

  1. Laboratory testing:

    • Prostate-specific antigen (PSA) 1, 3
    • Complete blood count
    • Coagulation studies if bleeding disorder suspected
  2. Imaging:

    • Transrectal ultrasound (TRUS) as first-line imaging 2, 1
      • Can identify calcifications, cysts, abscesses, ejaculatory duct obstruction, and prostate abnormalities
      • May be both diagnostic and therapeutic in certain cases (e.g., cyst drainage)
  3. Advanced imaging when TRUS is inconclusive or negative:

    • MRI of the prostate and seminal tract 2
      • Superior soft tissue contrast
      • Better visualization of seminal vesicles, ejaculatory ducts, and prostate
      • Preferred at 1.5T or 3T (3T offers better signal-to-noise ratio)
      • No endorectal coil needed with 3T MRI
  4. Additional procedures based on findings:

    • TRUS-guided aspiration or biopsy of seminal vesicles/prostate if:
      • Prostate cancer is suspected
      • Definitive diagnosis of a lesion is needed
      • Confirmation of ejaculatory duct obstruction is required 2

Special Considerations

  • CT scanning has limited value due to poor soft tissue contrast 2

  • Pelvic angiography should be reserved for intractable hematospermia when other evaluations have not revealed an etiology 2

  • Cystoscopy may be considered in cases with concurrent hematuria or when other evaluations are inconclusive

Common Pitfalls to Avoid

  1. Failure to stratify by age: Men ≥40 years require more thorough evaluation due to increased risk of underlying pathology 1, 3

  2. Overlooking iatrogenic causes: In men ≥40 years, the most common cause is often iatrogenic from urogenital instrumentation or prostate biopsy 3

  3. Missing systemic causes: Conditions like hypertension and bleeding disorders can contribute to hematospermia 3, 4

  4. Unnecessary imaging in young patients: For men <40 years with a single episode and no risk factors, extensive imaging is usually not indicated 2, 3

  5. Delayed referral: Persistent or recurrent hematospermia, especially with associated symptoms, warrants prompt urological referral

By following this structured approach, clinicians can appropriately evaluate hematospermia while avoiding unnecessary testing in low-risk patients and ensuring thorough evaluation in those at higher risk for significant underlying pathology.

References

Guideline

Male Infertility and Ejaculatory Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluation and treatment of hematospermia.

American family physician, 2009

Research

Hematospermia-a Symptom With Many Possible Causes.

Deutsches Arzteblatt international, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.